Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)

NCT02410356 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Growth Hormone Deficiency

Interventions

DRUG: TV-1106
DRUG: dGH

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.